先進治療薬の医薬品アウトソーシングの世界市場レポート 2025年

先進治療薬の医薬品アウトソーシング市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は5.1%で102億7,000万米ドルに成長します。予測期間の成長は、細胞・遺伝子治療の採用増加、mRNA治療への注目の高まり、最先端治療への需要の高まり、アウトソーシング・パートナーによる効率改善と費用対効果の高いソリューションの提供、共同イノベーションによるものです。予測期間の主な動向としては、技術進歩、先端治療法の専門知識の向上、革新的な治療法のパイプラインの増加、最先端技術の統合、遺伝子治療、細胞治療、mRNA技術の急速な進歩などが挙げられます。

細胞療法や遺伝子療法の採用増加が予想されることから、今後数年間は先進治療薬の医薬品アウトソーシング市場の拡大が見込まれます。細胞療法や遺伝子療法は、生きた細胞や遺伝物質を利用して疾病に対処し、治癒させる革新的な治療法であり、医療現場で脚光を浴びています。先進治療薬の医薬品アウトソーシングは、実績のあるプロバイダーや経験豊富な人材へのアクセスを許可することで、細胞・遺伝子治療をサポートする重要な役割を果たしています。この戦略的アプローチにより、企業は社内のチーム作りに費やす時間とリソースを節約することができます。英国の科学雑誌ネイチャー（Nature）の報告書によると、遺伝子治療による新規患者数は2020年の16,244人から2025年には94,696人になると予測されており、先進治療薬の医薬品アウトソーシング市場の成長の原動力となっています。

先進治療薬の医薬品アウトソーシング市場の有力企業は、サービス提供を強化し、顧客のニーズに効果的に応えるため、戦略的パートナーシップを積極的に推進しています。戦略的パートナーシップは、2つ以上の事業体（通常は企業）間の協力的な取り決めを特徴とし、各パートナーが単独で達成することが困難な、相互に有益な目標を達成することを目的としています。例えば、2023年1月、スイスに本社を置き、製薬、バイオテクノロジー、栄養分野にサービスを提供する製造会社であるロンザは、固形がん治療薬の開発を専門とする米国のバイオ医薬品会社であるコンテクスト・セラピューティクス社とパートナーシップを締結しました。この提携により、ロンザは、製造可能性評価、遺伝子・細胞株構築、原薬・製剤のプロセス開発などの主要サービスを提供し、コンテクスト・セラピューティクス社の取り組みを支援します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界先進治療薬の医薬品アウトソーシング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の先進治療薬の医薬品アウトソーシング市場：成長率分析
• 世界の先進治療薬の医薬品アウトソーシング市場の実績：規模と成長, 2019-2024
• 世界の先進治療薬の医薬品アウトソーシング市場の予測：規模と成長, 2024-2029, 2034F
• 世界先進治療薬の医薬品アウトソーシング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の先進治療薬の医薬品アウトソーシング市場：サービスタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 契約調査機関（CRO）
• 受託開発製造組織（CDMO）
• 世界の先進治療薬の医薬品アウトソーシング市場適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 神経学
• 心臓病学
• 感染症
• その他の適応症
• 世界の先進治療薬の医薬品アウトソーシング市場セラピーによって、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞療法
• 遺伝子治療
• RNAベースの治療法
• 世界の先進治療薬の医薬品アウトソーシング市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 前臨床サービス
• 臨床サービス
• 商業製造および包装
• 世界の先進治療薬の医薬品アウトソーシング市場、受託調査機関（CRO）の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 前調査サービス
• 臨床試験管理サービス
• 規制関連業務サービス
• データ管理と生物統計学
• 世界の先進治療薬の医薬品アウトソーシング市場、受託開発製造組織（CDMO）のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品開発サービス
• 処方開発
• 分析試験サービス
• 商業製造サービス

第7章 地域別・国別分析

• 世界の先進治療薬の医薬品アウトソーシング市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の先進治療薬の医薬品アウトソーシング市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 先進治療薬の医薬品アウトソーシング市場：競合情勢
• 先進治療薬の医薬品アウトソーシング市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • IQVIA Overview, Products and Services, Strategy and Financial Analysis
  • ICON plc Overview, Products and Services, Strategy and Financial Analysis
  • SGS SA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Lonza Group
• Parexel International Corporation
• WuXi AppTec
• Syneos Health
• Catalent Inc.
• Charles River Laboratories International
• Recipharm AB
• Croda International Plc
• Samsung Biologics
• Vetter Pharma International GmbH
• Medpace Holdings Inc.
• Fujifilm Diosynth Biotechnologies
• Marken
• AGC Biologics
• Evotec SE

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 先進治療薬の医薬品アウトソーシング市場2029：新たな機会を提供する国
• 先進治療薬の医薬品アウトソーシング市場2029：新たな機会を提供するセグメント
• 先進治療薬の医薬品アウトソーシング市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Advanced Therapeutic Pharmaceutical Outsourcing involves the delegation of specialized pharmaceutical services related to advanced therapeutic products. These products typically encompass advanced therapies such as cell and gene therapies, personalized medicines, biologics, and other innovative treatments. The outsourcing of these services is undertaken to leverage specialized expertise and capabilities in the production, testing, and development of advanced therapeutic products.

The primary services within advanced therapeutics pharmaceutical outsourcing include Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs). CROs and CDMOs offer a range of specialized services to support the development and commercialization of advanced therapeutic products. These services cater to various medical fields, including oncology, neurology, cardiology, infectious diseases, and others. Outsourcing activities may involve services related to cell therapy, gene therapy, and RNA-based therapies, covering preclinical services, clinical services, as well as commercial manufacturing and packaging applications.

The advanced therapeutics pharmaceutical outsourcing market research report is one of a series of new reports from The Business Research Company that provides advanced therapeutics pharmaceutical outsourcing market statistics, including advanced therapeutics pharmaceutical outsourcing industry global market size, regional shares, competitors with an advanced therapeutics pharmaceutical outsourcing market share, detailed advanced therapeutics pharmaceutical outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the advanced therapeutics pharmaceutical outsourcing industry. This advanced therapeutics pharmaceutical outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The advanced therapeutics pharmaceutical outsourcing market size has grown steadily in recent years. It will grow from $8.07 billion in 2024 to $8.43 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to growth in biopharmaceutical infrastructure, regulatory compliance, increasing demand for novel drugs to treat chronic and life-threatening diseases, improved efficiency, and growing demand for personalized medicine.

The advanced therapeutics pharmaceutical outsourcing market size is expected to see strong growth in the next few years. It will grow to $10.27 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to the increasing adoption of cell and gene therapies, The increasing focus on mRNA therapies, rising demand for cutting-edge treatments, improved efficiency and cost-effective solutions provided by outsourcing partners, and collaborative innovation. Major trends in the forecast period include technological advancement, rising expertise in advanced therapeutics, escalating pipeline of innovative therapies, the integration of cutting-edge technology, rapid advancements in gene therapy, cell therapy, and mRNA technologies.

The anticipated increase in the adoption of cell and gene therapies is set to drive the expansion of the advanced therapeutics pharmaceutical outsourcing market in the coming years. Cell and gene therapies, representing innovative treatments that leverage living cells or genetic material to address and cure diseases, have gained prominence in the medical landscape. Advanced therapeutics pharmaceutical outsourcing plays a crucial role in supporting cell and gene therapies by granting access to established providers with a proven track record and experienced personnel. This strategic approach allows companies to save both time and resources that would otherwise be spent on building in-house teams. Notably, a report by Nature, a UK-based scientific journal, projected a significant rise in the number of new patients treated with gene therapies, from 16,244 in 2020 to an estimated 94,696 in 2025, further affirming the driving force behind the growth of the advanced therapeutics pharmaceutical outsourcing market.

Prominent companies in the advanced therapeutics pharmaceutical outsourcing market are actively pursuing strategic partnerships to enhance their service offerings and cater to the needs of their customers effectively. A strategic partnership, characterized by a collaborative arrangement between two or more entities, typically businesses, aims to achieve mutually beneficial goals that may be challenging for each partner to accomplish independently. For instance, in January 2023, Lonza, a Switzerland-based manufacturing company serving the pharmaceutical, biotechnology, and nutrition sectors, entered into a partnership with Context Therapeutics Inc., a US-based biopharmaceutical company specializing in advancing medicines for solid tumors. This collaboration involves Lonza providing key services such as manufacturability assessment, gene and cell line construction, and process development for both drug substance and drug product in support of Context Therapeutics' initiatives.

In August 2022, Catalent Inc., a pharmaceutical company headquartered in the United States, completed the acquisition of Metrics Contract Services and Contract Development and Manufacturing Organization (CDMO) for a total of $475 million. This strategic acquisition is poised to enhance Catalent's expertise in integrated oral solid formulation development, manufacturing, and packaging, thereby enabling customers to streamline and expedite their programs. Additionally, the acquisition will broaden Catalent's capacity to manage highly potent compounds. Metrics Contract Services and Contract Development and Manufacturing Organization (CDMO), a US-based provider offering specialized services for drug development and manufacturing, was identified as a key asset to reinforce Catalent's position in the pharmaceutical industry.

Major companies operating in the advanced therapeutics pharmaceutical outsourcing market report are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, IQVIA, ICON plc, SGS SA, Lonza Group, Parexel International Corporation, WuXi AppTec, Syneos Health, Catalent Inc., Charles River Laboratories International, Recipharm AB, Croda International Plc, Samsung Biologics, Vetter Pharma International GmbH, Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies, Marken, AGC Biologics, Evotec SE, ProPharma Group, Piramal Pharma Solutions, Corden Pharma International LLC, Novotech Pty Ltd., Cryoport Systems Inc., Cytovance Biologics

North America was the largest region in the advanced therapeutics pharmaceutical outsourcing market in 2024. The regions covered in the advanced therapeutics pharmaceutical outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the advanced therapeutics pharmaceutical outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The advanced therapeutics pharmaceutical outsourcing market includes revenues earned by entities by providing services such as research and development support, process development and manufacturing, comprehensive analytical testing and characterization, regulatory support, clinical manufacturing, commercial manufacturing, implementation of quality systems, consulting and strategic services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Advanced Therapeutics Pharmaceutical Outsourcing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on advanced therapeutics pharmaceutical outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for advanced therapeutics pharmaceutical outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The advanced therapeutics pharmaceutical outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Service Type: Contract Research Organizations (CROs); Contract Development And Manufacturing Organizations (CDMOs)
• 2) By Indication: Oncology; Neurology; Cardiology; Infectious Diseases; Other Indications
• 3) By Therapy: Cell Therapy; Gene Therapy; RNA-based Therapies
• 4) By Application: Preclinical Services; Clinical Services; Commercial Manufacturing And Packaging
• Subsegments:
• 1) By Contract Research Organizations (CROs): Preclinical Research Services; Clinical Trial Management Services; Regulatory Affairs Services; Data Management And Biostatistics
• 2) By Contract Development And Manufacturing Organizations (CDMOs): Drug Development Services; Formulation Development; Analytical Testing Services; Commercial Manufacturing Services
• Companies Mentioned: Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; IQVIA; ICON plc; SGS SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Advanced Therapeutics Pharmaceutical Outsourcing Market Characteristics

3. Advanced Therapeutics Pharmaceutical Outsourcing Market Trends And Strategies

4. Advanced Therapeutics Pharmaceutical Outsourcing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Advanced Therapeutics Pharmaceutical Outsourcing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Advanced Therapeutics Pharmaceutical Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Growth Rate Analysis
• 5.4. Global Advanced Therapeutics Pharmaceutical Outsourcing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Advanced Therapeutics Pharmaceutical Outsourcing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Advanced Therapeutics Pharmaceutical Outsourcing Total Addressable Market (TAM)

6. Advanced Therapeutics Pharmaceutical Outsourcing Market Segmentation

• 6.1. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contract Research Organizations (CROs)
• Contract Development And Manufacturing Organizations (CDMOs)
• 6.2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Neurology
• Cardiology
• Infectious Diseases
• Other Indications
• 6.3. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Therapy
• Gene Therapy
• RNA-based Therapies
• 6.4. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Preclinical Services
• Clinical Services
• Commercial Manufacturing And Packaging
• 6.5. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Sub-Segmentation Of Contract Research Organizations (CROs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Preclinical Research Services
• Clinical Trial Management Services
• Regulatory Affairs Services
• Data Management And Biostatistics
• 6.6. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Sub-Segmentation Of Contract Development And Manufacturing Organizations (CDMOs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Development Services
• Formulation Development
• Analytical Testing Services
• Commercial Manufacturing Services

7. Advanced Therapeutics Pharmaceutical Outsourcing Market Regional And Country Analysis

• 7.1. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market

• 8.1. Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Advanced Therapeutics Pharmaceutical Outsourcing Market

• 9.1. China Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 9.2. China Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Advanced Therapeutics Pharmaceutical Outsourcing Market

• 10.1. India Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Advanced Therapeutics Pharmaceutical Outsourcing Market

• 11.1. Japan Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 11.2. Japan Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Advanced Therapeutics Pharmaceutical Outsourcing Market

• 12.1. Australia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Advanced Therapeutics Pharmaceutical Outsourcing Market

• 13.1. Indonesia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market

• 14.1. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 14.2. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Advanced Therapeutics Pharmaceutical Outsourcing Market

• 15.1. Western Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 15.2. Western Europe Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Advanced Therapeutics Pharmaceutical Outsourcing Market

• 16.1. UK Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Advanced Therapeutics Pharmaceutical Outsourcing Market

• 17.1. Germany Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Advanced Therapeutics Pharmaceutical Outsourcing Market

• 18.1. France Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Advanced Therapeutics Pharmaceutical Outsourcing Market

• 19.1. Italy Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Advanced Therapeutics Pharmaceutical Outsourcing Market

• 20.1. Spain Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Advanced Therapeutics Pharmaceutical Outsourcing Market

• 21.1. Eastern Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 21.2. Eastern Europe Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Advanced Therapeutics Pharmaceutical Outsourcing Market

• 22.1. Russia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Advanced Therapeutics Pharmaceutical Outsourcing Market

• 23.1. North America Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 23.2. North America Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Advanced Therapeutics Pharmaceutical Outsourcing Market

• 24.1. USA Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 24.2. USA Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market

• 25.1. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 25.2. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Advanced Therapeutics Pharmaceutical Outsourcing Market

• 26.1. South America Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 26.2. South America Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Market

• 27.1. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Advanced Therapeutics Pharmaceutical Outsourcing Market

• 28.1. Middle East Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 28.2. Middle East Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Advanced Therapeutics Pharmaceutical Outsourcing Market

• 29.1. Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 29.2. Africa Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Advanced Therapeutics Pharmaceutical Outsourcing Market Competitive Landscape And Company Profiles

• 30.1. Advanced Therapeutics Pharmaceutical Outsourcing Market Competitive Landscape
• 30.2. Advanced Therapeutics Pharmaceutical Outsourcing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. IQVIA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. ICON plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. SGS SA Overview, Products and Services, Strategy and Financial Analysis

31. Advanced Therapeutics Pharmaceutical Outsourcing Market Other Major And Innovative Companies

• 31.1. Lonza Group
• 31.2. Parexel International Corporation
• 31.3. WuXi AppTec
• 31.4. Syneos Health
• 31.5. Catalent Inc.
• 31.6. Charles River Laboratories International
• 31.7. Recipharm AB
• 31.8. Croda International Plc
• 31.9. Samsung Biologics
• 31.10. Vetter Pharma International GmbH
• 31.11. Medpace Holdings Inc.
• 31.12. Fujifilm Diosynth Biotechnologies
• 31.13. Marken
• 31.14. AGC Biologics
• 31.15. Evotec SE

32. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Advanced Therapeutics Pharmaceutical Outsourcing Market

34. Recent Developments In The Advanced Therapeutics Pharmaceutical Outsourcing Market

35. Advanced Therapeutics Pharmaceutical Outsourcing Market High Potential Countries, Segments and Strategies

• 35.1 Advanced Therapeutics Pharmaceutical Outsourcing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Advanced Therapeutics Pharmaceutical Outsourcing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Advanced Therapeutics Pharmaceutical Outsourcing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer